Mehdi Lahmar

3PUBLICATIONS
29CO-AUTHORS
Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 10, 2026
Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|Jun 03, 2023
The MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study.

Patricia LoRusso, Noboru Yamamoto, Manish R Patel

|Mar 29, 2023
Brightline-1: phase II/III trial of the MDM2-p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS.

Patrick Schöffski, Mehdi Lahmar, Anthony Lucarelli

Pageof 1

Frequent Collaborators

2 joint publications

Patricia LoRusso

2 joint publications

Michael Teufel

1 joint publications

Noboru Yamamoto

1 joint publications

Manish R Patel

1 joint publications

Scott A Laurie

1 joint publications

Todd M Bauer

1 joint publications

Junxian Geng

1 joint publications

Teffany Davenport

1 joint publications

Jian Li

1 joint publications

Mrinal M Gounder

Frequent Collaborators

2 joint publications

Patricia LoRusso

2 joint publications

Michael Teufel

1 joint publications

Noboru Yamamoto

1 joint publications

Manish R Patel

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us